Biological Risk Intelligence within UNOSINT Framework
BIOINT delivers integrated biological risk intelligence fusing genomic surveillance, epidemiological analysis, biosecurity monitoring, and One Health assessment into unified situational awareness. Purpose-built for public health authorities, biosecurity agencies, health security programs, and institutional risk managers requiring evidence-grade intelligence across the biological threat landscape.
From pathogen genomic characterization and outbreak detection to antimicrobial resistance tracking, synthetic biology monitoring, and deliberate release assessment—BIOINT provides the analytical foundation for pandemic preparedness, biosecurity policy, and health emergency response across natural, accidental, and deliberate biological threats.
UNOSINT Technical Architecture & Full Nexus Ecosystem Stack →
Biological risks span naturally emerging pathogens, antimicrobial resistance, laboratory accidents, climate-driven disease expansion, and deliberate misuse. Effective preparedness requires integrated intelligence correlating human, animal, and environmental health domains while maintaining the analytical rigor demanded by health security stakeholders.
Real-time outbreak detection and characterization through syndromic surveillance integration, case clustering analysis, reproductive number estimation (R₀, Rₜ), serial interval calculation, and healthcare capacity correlation for surge planning and resource allocation.
Pathogen sequencing data integration from GISAID, GenBank, and national repositories. Variant tracking via Pangolin/Nextclade classification, mutation monitoring for immune escape, transmissibility changes, and virulence shifts. Phylogenetic analysis for outbreak cluster identification.
Laboratory biosafety incident monitoring across BSL-3/4 facilities. Dual-use research of concern (DURC) tracking, gain-of-function research oversight, select agent compliance monitoring, synthetic biology risk assessment, and deliberate release threat characterization.
Unified surveillance across human-animal-environment interfaces. Wildlife health monitoring, livestock disease tracking via WOAH-WAHIS, zoonotic spillover risk assessment, vector surveillance, wastewater epidemiology, and climate-health correlation analysis.
Vaccine development pipeline tracking (preclinical through authorization), therapeutic development monitoring, diagnostic landscape intelligence, stockpile status assessment, manufacturing capacity analysis, and 100 Days Mission alignment for rapid MCM deployment.
Global AMR surveillance integration via WHO GLASS, regional networks (EARS-Net, CAESAR), resistance gene tracking, ESKAPE pathogen monitoring, antifungal resistance assessment, and antibiotic consumption correlation for stewardship program support.
BIOINT integrates specialized collection and analysis across infectious disease surveillance, genomic intelligence, One Health monitoring, biosecurity, and climate-health domains—each discipline maintaining methodological rigor while contributing to unified biological risk assessment.
Infectious Disease Monitoring
Emerging infectious disease tracking, novel pathogen detection, spillover event monitoring, pandemic potential assessment per WHO/CDC/ECDC priority lists. Disease X preparedness intelligence.
Sequencing & Phylogenetics
Pathogen WGS integration, variant classification (Pangolin, Nextclade), lineage tracking, mutation surveillance for immune escape/transmissibility, phylogenetic analysis, molecular epidemiology, cryptic transmission detection.
Drug Resistance Surveillance
AMR gene detection (ResFinder, CARD), resistance pattern tracking, ESKAPE pathogen monitoring, carbapenemase surveillance, antifungal resistance, antibiotic consumption integration.
Animal-Human Interface
Wildlife health monitoring, livestock disease surveillance via WAHIS, spillover risk assessment, bushmeat trade tracking, wet market monitoring, bat/rodent reservoir surveillance, interface hotspot mapping.
Laboratory & Dual-Use
BSL-3/4 facility monitoring, laboratory incident tracking, dual-use research of concern (DURC), gain-of-function oversight, select agent compliance, insider threat indicators, acquisition intelligence.
Emerging Technology Risks
Gene synthesis screening (IGSC), CRISPR accessibility monitoring, DIY biology community tracking, benchtop sequencing proliferation, enhanced pathogen potential (ePP) assessment, gene drive developments.
Vaccines, Therapeutics, Diagnostics
Vaccine development pipeline (preclinical→Phase 3→EUA), therapeutic candidates, diagnostic availability, stockpile status, manufacturing capacity, supply chain vulnerabilities, 100 Days Mission tracking.
Environmental Biosurveillance
Wastewater-based epidemiology (WBE), pathogen RNA/DNA detection (qPCR, dPCR), community prevalence estimation, variant tracking via sewage sequencing, poliovirus surveillance, opioid monitoring.
BIOINT implements rigorous structured analytic techniques adapted for biological risk intelligence—reducing cognitive bias, documenting analytical reasoning, and enabling reproducible assessments aligned with epidemiological and biosecurity tradecraft.
BIOINT implements a modified Admiralty-based source reliability framework calibrated for biological data sources—enabling analysts to systematically assess and document confidence in epidemic intelligence, genomic data, and biosurveillance reports.
WHO/CDC/ECDC official reports, peer-reviewed publications, validated laboratory networks (GOARN, GISRS)
National health ministry reports, established surveillance systems (EWRS, NNDSS), major academic institutions
Provincial/state health departments, hospital networks, ProMED verified reports, regional surveillance
Media reports, unverified social media, single-source informal reports, commercial intelligence without validation
Anonymous tips, sources with known accuracy issues, politically compromised reporting systems
New sources with insufficient track record, novel data streams requiring validation
Laboratory-confirmed cases, sequenced isolates, multiple independent verification
Clinically compatible cases, epidemiological linkage, corroborated by reliable secondary sources
Suspected cases meeting case definition, single-source reports from reliable sources
Rumors with some supporting evidence, reports inconsistent with epidemiological expectations
Information contradicting established evidence, likely misinformation
Insufficient context for credibility assessment, requires further verification
BIOINT implements the complete intelligence cycle for biological risk applications—from requirements definition through collection, processing, analysis, and dissemination—with documented audit trails meeting health security accountability standards.
Automated anomaly detection across syndromic, laboratory, and mortality data streams. Statistical aberration detection (CUSUM, EARS-C), cluster identification, signal verification workflows integrated with IHR notification requirements.
Real-time Rₜ estimation (EpiEstim, EpiNow2), serial interval analysis, generation time calculation, attack rate projections, hospitalization/mortality forecasting with ensemble methods and uncertainty quantification.
Pathogen characterization (transmissibility, severity, immune escape), pandemic potential scoring (IRAT, TIPRA), deliberate release indicator analysis, ICD 203-aligned confidence statements with evidence grading.
Integrated dashboards correlating epidemiological, genomic, healthcare capacity, and intervention effectiveness data. Geographic visualization, temporal trend analysis, what-if scenario modeling for policy planning.
Real-time variant tracking, mutation monitoring for functional significance (RBD, furin cleavage), immune escape assessment, growth advantage estimation, phylogeographic spread analysis.
Laboratory incident tracking, dual-use research oversight, synthetic biology monitoring, acquisition indicator detection, deliberate release signature analysis, attribution support for bioforensics.
Cross-domain correlation of human, animal, and environmental health signals. Spillover risk modeling, wildlife die-off correlation, vector population dynamics, land-use change impact assessment.
Vaccine/therapeutic pipeline tracking, effectiveness monitoring, variant-MCM matching, stockpile status, manufacturing capacity assessment, supply chain vulnerability identification.
Comprehensive surveillance across the human-animal-environment interface, recognizing that over 75% of emerging infectious diseases originate at ecosystem boundaries where species interact. BIOINT enables true One Health situational awareness.
BIOINT provides specialized intelligence products aligned with each phase of the pandemic preparedness and response lifecycle—from baseline capacity assessment through response operations and recovery.
Spillover hotspot mapping, reservoir surveillance, dual-use research tracking, laboratory biosafety monitoring, synthetic biology oversight, wildlife trade interdiction support.
Syndromic anomaly detection, event-based surveillance (ProMED, HealthMap), wastewater early warning, genomic signal detection, IHR notification support.
Transmission modeling, healthcare capacity forecasting, variant tracking, MCM effectiveness monitoring, contact tracing optimization, NPI impact assessment.
Long-COVID surveillance, healthcare system recovery tracking, economic impact assessment, after-action review support, lessons learned synthesis, endemic transition monitoring.
JEE/SPAR gap analysis, IHR core capacity assessment, simulation exercise support, stockpile optimization, surge capacity modeling, workforce readiness evaluation.
BIOINT implements international health security standards enabling interoperability with existing surveillance systems, WHO frameworks, and global health security architecture.
International Health Regulations core capacities, PHEIC determination support
Global Health Security Agenda action packages, 11 technical areas
Joint External Evaluation, 19 technical areas, capacity scoring
State Party Self-Assessment Annual Reporting
National Action Plans for Health Security, costed plans
WOAH Performance of Veterinary Services
Healthcare interoperability, case reports, lab results
International Classification of Diseases, mortality coding
Clinical terminology, pathogen/symptom coding
Laboratory test codes, result standardization
Clinical document architecture, case reporting
District Health Information System, aggregate data
Genomic sequences, EpiCoV, EpiFlu databases
Event-based surveillance, outbreak alerts
Global Public Health Intelligence Network
World Animal Health Information System
FAO Emergency Prevention System
Global Antimicrobial Resistance Surveillance
Biological Weapons Convention, CBM reporting
Non-proliferation, national implementation
Export control lists, common control lists
Laboratory biorisk management standard
Federal Select Agent Program regulations
Biosafety, LMO transboundary movement
BIOINT addresses the full spectrum of biological risks—natural, accidental, and deliberate—providing unified intelligence across threat categories that often require coordinated multi-sector response.
Novel pathogen spillover, pandemic-potential pathogens, epidemic outbreaks, Disease X preparedness, respiratory virus variants, hemorrhagic fevers, NTDs with outbreak potential.
Vaccine-preventable disease outbreaks (measles, polio), tuberculosis resurgence, malaria elimination threats, cholera, endemic mycoses, parasitic disease burden.
MDR/XDR bacteria (CRE, MRSA, VRE), drug-resistant TB, antifungal resistance (Candida auris), antimalarial resistance, antiviral resistance emergence.
BSL-3/4 containment breaches, occupational exposures, inadvertent releases, select agent violations, gain-of-function research incidents, sample mishandling, shipment errors.
Deliberate release indicators, Category A agents (anthrax, smallpox, plague, botulinum), agricultural bioterrorism, insider threats, acquisition intelligence, state programs.
Gene synthesis screening gaps, CRISPR accessibility, DIY biology community, enhanced pathogen potential (ePP), gene drives, de novo pathogen construction feasibility.
Foodborne pathogen outbreaks (Salmonella, E. coli O157, Listeria), contamination trace-back, supply chain attribution, RASFF/INFOSAN alerts, recall intelligence.
Aedes mosquito range expansion, tick-borne disease emergence (Lyme, TBE), arbovirus spread (dengue, Zika, chikungunya, WNV), climate-vector modeling.
Wildlife-to-human transmission, livestock disease spillover (H5N1, H7N9), wet market monitoring, bushmeat trade, bat reservoir surveillance, rodent-borne pathogens.
Botulinum toxin, ricin, abrin, saxitoxin, natural toxin contamination (shellfish, ciguatera), mycotoxins, chemical-biological interface threats.
Healthcare-associated infections (HAIs), surgical site infections, central line infections, ventilator-associated pneumonia, Clostridioides difficile, hospital cluster detection.
Healthcare surge capacity, PPE/MCM supply chain, workforce resilience, cross-border health security, pandemic cascading effects, essential service continuity.
BIOINT implements an extensible entity-relationship model enabling multi-source biological data correlation, cross-domain querying, and knowledge graph-based inference for complex epidemiological and biosecurity analysis.
BIOINT serves the diverse intelligence requirements of health security stakeholders while maintaining appropriate access controls, classification handling, and information sharing protocols aligned with international norms.
WHO, national health ministries, state/provincial health departments, local health departments, FETP programs, GOARN deployable experts.
Needs: Early warning, outbreak investigation, IHR notification support, situation reports, risk assessment, contact tracing optimization
Biodefense agencies, intelligence community, military medical commands, homeland security, law enforcement, CBRN response teams.
Needs: Threat assessment, deliberate release detection, attribution support, bioforensics, countermeasure planning, exercise support
Hospital networks, infection prevention programs, clinical laboratories, healthcare coalitions, medical supply chains, pharmacy networks.
Needs: Surge planning, infection control guidance, diagnostic intelligence, treatment protocols, capacity forecasting, HAI prevention
Vaccine developers, diagnostic companies, pharmaceutical firms, academic institutions, biotech companies, clinical trial networks.
Needs: Pathogen characterization, variant tracking, clinical trial site selection, regulatory intelligence, R&D prioritization
National veterinary services, WOAH/FAO, livestock industry, wildlife agencies, aquaculture sector, companion animal networks.
Needs: Zoonotic surveillance, livestock disease tracking, spillover risk, trade implications, vaccination programs, AMR in agriculture
WHO country offices, UNICEF, MSF, ICRC, bilateral donors (USAID, FCDO), development banks, NGO implementers.
Needs: Outbreak response coordination, health system strengthening, refugee health, disease burden assessment, program evaluation
National security councils, pandemic preparedness offices, legislative health committees, regulatory agencies, international organizations.
Needs: Strategic intelligence briefs, policy impact analysis, regulatory intelligence, international agreement tracking, scenario planning
Pandemic risk insurance, World Bank PEF, IFC health investments, ESG analysts, supply chain insurers, catastrophe modeling firms.
Needs: Risk quantification, pandemic bond triggers, portfolio exposure, supply chain risk, ESG health security metrics
Structured programs advancing biological intelligence capabilities through open collaboration, funded research challenges, and applied development initiatives aligned with global health security priorities.
Multi-year research initiatives advancing outbreak detection algorithms, genomic surveillance methodologies, wastewater epidemiology, and One Health data integration frameworks.
Focus Areas: Novel data sources, predictive modeling, early warning systems, syndromic surveillance innovation, AI/ML for epidemic intelligence
Targeted challenges addressing specific capability gaps: AMR gene detection pipelines, variant characterization tools, spillover prediction models, biosecurity threat indicators.
Format: Time-boxed challenges, clearly scoped deliverables, peer-reviewed acceptance criteria, open-source contribution pathway
Applied development projects creating deployable tools: contact tracing systems, outbreak investigation platforms, genomic analysis pipelines, risk communication frameworks.
Deliverables: Production-ready code, comprehensive documentation, field-tested with emergency response partners, deployment support
Intensive collaborative events bringing together epidemiologists, bioinformaticians, data scientists, and health security practitioners for rapid prototyping and innovation.
Topics: Pandemic preparedness tools, AMR analytics platforms, One Health integration, wastewater surveillance dashboards
Flexible engagement options enabling health security organizations to leverage BIOINT capabilities aligned with their mission, capacity, and operational requirements.
Individual analyst and team access to BIOINT intelligence feeds, analytical tools, collaboration networks, training resources, and community forums.
Learn MoreStrategic collaboration for health ministries, research institutions, and international organizations—joint capability development, data sharing, co-branded programs.
Explore PartnershipFund specific R&D initiatives, biosurveillance quests, health security bounties, or infrastructure development aligned with sponsor health security priorities.
Sponsor ProgramsEmbedded expert programs for epidemiologists, biosecurity specialists, and health security professionals contributing to and advancing BIOINT capabilities.
Apply for FellowshipBIOINT services address the full spectrum of health security requirements—from routine surveillance support to emergency response coordination, strategic biosecurity assessment, and pandemic preparedness planning.
BIOINT operates within the Nexus Platform ecosystem, enabling seamless integration with broader risk intelligence, policy analysis, governance frameworks, and resilience-building initiatives across the de-risking value chain.
BIOINT operates as non-profit critical infrastructure for global health security, with transparent funding mechanisms enabling institutional sustainability while maintaining equitable access to core biosurveillance capabilities aligned with health security as a global public good.
Contribution incentives for epidemic intelligence analysts, genomic surveillance contributors, biosecurity researchers, and field epidemiologists strengthening the BIOINT collective intelligence base.
Multiple funding mechanisms ensuring BIOINT sustainability while maintaining non-profit mission alignment and equitable global access to health security intelligence.
BIOINT implements distributed verification mechanisms enabling global health security community participation in outbreak signal validation, reducing false positives while accelerating time-to-confirmation for genuine public health events.
Immutable audit trails for intelligence products, contributor attribution, and analytical reasoning chains enabling reproducibility and accountability.
Dynamic reputation scores for surveillance networks, laboratories, and reporting systems based on historical accuracy, timeliness, and verification rates.
Structured peer review mechanisms enabling subject matter experts to validate signals, challenge assessments, and contribute domain expertise.
Anomaly detection for coordinated inauthentic reporting, statistical signatures of data manipulation, and cross-validation against independent streams.
BIOINT is designed around IHR (2005) core capacity requirements—supporting event detection, risk assessment, and notification workflows. Our early warning capabilities help National IHR Focal Points meet 24-hour notification requirements while providing the evidence base for PHEIC determinations. We align with JEE 3.0 technical areas and support NAPHS development with gap analysis and remediation tracking.
Native integration with GISAID (EpiCoV, EpiFlu), GenBank, and national sequence repositories. We support standard formats (FASTA, VCF, BAM) and implement Pangolin, Nextclade, and Nextstrain for variant classification. Phylogenetic analysis uses IQ-TREE, BEAST, and TreeTime for outbreak cluster identification, transmission chain reconstruction, and molecular clock dating.
BIOINT maintains indicator libraries distinguishing natural outbreaks from deliberate releases—including epidemiological anomalies (simultaneous multipoint emergence, unusual victim demographics), strain characteristics (engineered markers, atypical resistance profiles), and acquisition signatures. We support BWC compliance monitoring, DURC research oversight, and integrate with law enforcement workflows while maintaining appropriate classification boundaries.
We integrate WOAH WAHIS (animal health), FAO EMPRES-i, ProMED-mail, HealthMap, and national veterinary surveillance systems. Environmental health data includes wastewater surveillance networks (NWSS, EWASH), vector monitoring programs (VectorBase), and climate-health correlation datasets. This enables spillover event detection at human-animal-environment interfaces with interface hotspot mapping.
BIOINT provides pathogen characterization supporting the 100 Days Mission—including variant surveillance for immune escape mutations affecting vaccine effectiveness, clinical trial site selection based on disease burden and circulating strains, and regulatory landscape intelligence. We track development pipelines from preclinical through authorization, monitor post-market effectiveness, and assess variant-MCM matching for stockpile management.
The Global Centre for Risk and Innovation (GCRI-US/Canada), Global Risks Forum (GRF-Switzerland), and Global Risks Alliance (GRA-US) collectively develop and maintain BIOINT as non-profit health security infrastructure. We operate as system integrators—not vendors—enabling open collaboration among public health authorities, research institutions, biosecurity agencies, and global health partners worldwide under the UNOSINT framework.
Wastewater-based epidemiology (WBE) provides population-level pathogen detection with 7-14 day lead time before clinical case surges. BIOINT integrates NWSS, European networks, and national programs, supporting qPCR/dPCR quantification, sewage sequencing for variant tracking, normalization across catchments, and correlation with clinical surveillance for early warning validation and trend confirmation.
We integrate WHO GLASS data, regional networks (EARS-Net, CAESAR, ReLAVRA), and national AMR surveillance systems. Capabilities include resistance gene detection (ResFinder, CARD databases), ESKAPE pathogen priority tracking, plasmid epidemiology, antibiotic consumption correlation, and treatment guidance development. We support National Action Plan implementation and clinical stewardship program intelligence.
From outbreak detection to pandemic response coordination. From genomic surveillance to biosecurity monitoring. From One Health integration to MCM intelligence. BIOINT delivers the analytical foundation health security stakeholders require for all-hazards biological risk management.
Multi-source biological risk intelligence | One Health surveillance integration | Genomic & syndromic analysis | Biosecurity monitoring | Pandemic preparedness support
BIOINT operates within the Universal Nexus Open Source Intelligence (UNOSINT) framework, developed by the Global Centre for Risk and Innovation (GCRI), Global Risks Forum (GRF), and Global Risks Alliance (GRA) as non-profit health security infrastructure for the global community.